RU2018135961A - Способ ускорения инволюции и предотвращения инфекции молочной железы дойного животного при запуске - Google Patents
Способ ускорения инволюции и предотвращения инфекции молочной железы дойного животного при запуске Download PDFInfo
- Publication number
- RU2018135961A RU2018135961A RU2018135961A RU2018135961A RU2018135961A RU 2018135961 A RU2018135961 A RU 2018135961A RU 2018135961 A RU2018135961 A RU 2018135961A RU 2018135961 A RU2018135961 A RU 2018135961A RU 2018135961 A RU2018135961 A RU 2018135961A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- chitosan
- composition according
- nipples
- kda
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Claims (15)
1. Композиция для предотвращения интрамаммарной инфекции или для ускорения инволюции у дойного животного во время запуска, включающая модификатор биологического ответа и приемлемый носитель.
2. Композиция по п. 1, в которой модификатор биологического ответа содержит хитозановый гидрогель, включающий хитозан и слабое основание.
3. Композиция по п. 2, в которой степень деацетилирования хитозана составляет более 90%.
4. Композиция по п. 2 или 3, в которой средневесовая молекулярная масса хитозана составляет от приблизительно 110 кДа до приблизительно 250 кДа.
5. Композиция по п. 4, в которой средневесовая молекулярная масса хитозана составляет от приблизительно 160 кДа до приблизительно 170 кДа.
6. Композиция по п. 5, в которой хитозан имеет вязкость от приблизительно 90 сантипуаз до приблизительно 130 сантипуаз.
7. Композиция по любому из пп. 2-6, в которой слабое основание имеет значение pKa от приблизительно 6 до приблизительно 7.
8. Композиция по любому из пп. 2-7, в которой слабое основание является β-глицерофосфатом.
9. Композиция по любому из пп. 2-8, в которой модификатор биологического ответа имеет значение рН равное 6,8.
10. Способ предотвращения интрамаммарных инфекций у дойного животного во время запуска, включающий введение композиции по любому из пп. 1-9 в один или несколько сосков дойного животного.
11. Способ по п. 10, в котором дойное животное является представителем крупного рогатого скота.
12. Способ по п. 10 или 11 в котором введение композиции включает инъекцию композиции в один или несколько сосков дойного животного.
13. Способ ускорения инволюции у дойного животного во время запуска, включающий введение композиции по любому из пп. 1-9 в один или несколько сосков дойного животного.
14. Способ по п. 13, в котором дойное животное является представителем крупного рогатого скота.
15. Способ по п. 13 или 14, в котором введение композиции включает инъекцию композиции в один или несколько сосков дойного животного.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662310025P | 2016-03-18 | 2016-03-18 | |
| US62/310,025 | 2016-03-18 | ||
| PCT/CA2017/050339 WO2017156632A1 (en) | 2016-03-18 | 2017-03-16 | Chitosan hydrogels for accelerating involution and preventing infection of the mammary gland at drying-off |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2018135961A true RU2018135961A (ru) | 2020-04-20 |
Family
ID=59850126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018135961A RU2018135961A (ru) | 2016-03-18 | 2017-03-16 | Способ ускорения инволюции и предотвращения инфекции молочной железы дойного животного при запуске |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10828319B2 (ru) |
| EP (1) | EP3429601A4 (ru) |
| CN (1) | CN109310705A (ru) |
| AU (1) | AU2017233727A1 (ru) |
| BR (1) | BR112018068794A2 (ru) |
| CA (1) | CA3015846A1 (ru) |
| CL (1) | CL2018002562A1 (ru) |
| CO (1) | CO2018011133A2 (ru) |
| MX (1) | MX2018011350A (ru) |
| RU (1) | RU2018135961A (ru) |
| WO (1) | WO2017156632A1 (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018254458A1 (en) * | 2017-04-20 | 2019-10-17 | Zoetis Services Llc | Veterinary compositions for use in treating mastitis, and associated methods |
| EP4064854A1 (en) | 2019-11-28 | 2022-10-05 | Boehringer Ingelheim Vetmedica GmbH | Use of sglt-2 inhibitors in the drying-off of non-human mammals |
| CN111840212B (zh) * | 2020-06-18 | 2023-07-21 | 余祖功 | 一种非人类动物用乳头封闭剂及其制备方法 |
| CN120168507B (zh) * | 2025-05-21 | 2025-09-19 | 中国农业大学 | 一种“回奶型”无抗干奶组合物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2212300A1 (en) | 1997-08-04 | 1999-02-04 | Abdellatif Chenite | In vitro or in vivo gelfying chitosan and therapeutic uses thereof |
| WO2003042250A1 (en) | 2001-11-15 | 2003-05-22 | Biosyntech Canada Inc. | Composition and method to homogeneously modify or cross-link chitosan under neutral conditions |
| US20050191270A1 (en) * | 2004-02-27 | 2005-09-01 | Hydromer, Inc. | Anti-infectious hydrogel compositions |
| WO2015093937A1 (en) * | 2013-12-19 | 2015-06-25 | N.V. Nutricia | Lactobacillus salivarius for the treatment of mastitis |
| MX374683B (es) | 2015-11-03 | 2025-03-04 | Zoetis Services Llc | Compuestos polimericos sol-gel y sus usos. |
-
2017
- 2017-03-16 RU RU2018135961A patent/RU2018135961A/ru not_active Application Discontinuation
- 2017-03-16 CN CN201780017905.1A patent/CN109310705A/zh active Pending
- 2017-03-16 WO PCT/CA2017/050339 patent/WO2017156632A1/en not_active Ceased
- 2017-03-16 AU AU2017233727A patent/AU2017233727A1/en not_active Abandoned
- 2017-03-16 CA CA3015846A patent/CA3015846A1/en active Pending
- 2017-03-16 US US16/085,691 patent/US10828319B2/en not_active Expired - Fee Related
- 2017-03-16 BR BR112018068794A patent/BR112018068794A2/pt not_active Application Discontinuation
- 2017-03-16 EP EP17765617.0A patent/EP3429601A4/en not_active Withdrawn
- 2017-03-16 MX MX2018011350A patent/MX2018011350A/es unknown
-
2018
- 2018-09-07 CL CL2018002562A patent/CL2018002562A1/es unknown
- 2018-10-17 CO CONC2018/0011133A patent/CO2018011133A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3015846A1 (en) | 2017-09-21 |
| CO2018011133A2 (es) | 2018-10-31 |
| BR112018068794A2 (pt) | 2019-04-09 |
| US20190060352A1 (en) | 2019-02-28 |
| EP3429601A4 (en) | 2019-11-27 |
| US10828319B2 (en) | 2020-11-10 |
| EP3429601A1 (en) | 2019-01-23 |
| CL2018002562A1 (es) | 2019-02-15 |
| MX2018011350A (es) | 2019-06-06 |
| WO2017156632A1 (en) | 2017-09-21 |
| CN109310705A (zh) | 2019-02-05 |
| AU2017233727A1 (en) | 2018-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018135961A (ru) | Способ ускорения инволюции и предотвращения инфекции молочной железы дойного животного при запуске | |
| MX2018005547A (es) | Compuestos polimericos sol-gel y sus usos. | |
| EA201591812A1 (ru) | Противомикробные полиамидные композиции и лечение мастита | |
| MX389697B (es) | Nuevos derivados de pirazolopirimidina. | |
| EP3838978A3 (en) | Nucleated crystallization of poly(trimethylene-2,5-furandicarboxylate) (ptf) and articles made therefrom | |
| MX2021004558A (es) | Polimeros de union a protones para administracion oral. | |
| ZA202201712B (en) | Method for determining the risk of an avian pathogenic e. coli (apec) infection in an avian flock | |
| MX2018007055A (es) | Composiciones blanqueadoras de cuidado bucal. | |
| EP4606375A3 (en) | Antibacterial compounds | |
| MX2018006190A (es) | Antibioticos de amplio espectro macrociclico. | |
| MX2018008856A (es) | Composiciones para mejorar el uso de nitrogeno en un rumiante. | |
| MX2020008359A (es) | Uso de ácido (1s,3s)-3-amino-4-(difluorometiliden) ciclopentano-1-carboxílico y ácido (s)-3-amino-4-(difluorometileni l)ciclopent-1-eno-1-carboxílico en el tratamiento del tinnitus, pérdida de audición neurosensorial aguda, enfermedad de meniere, síndrome de tourette, trastorno por déficit de atención e hiperactividad y adicción. | |
| WO2018109042A3 (en) | Antimicrobial peptides | |
| EP3953339C0 (en) | PROCESS FOR THE PREPARATION OF 1-DEOXY-1-METHYLAMINO-D-GLUCITOL 2-(3,5-DICHLOROPHENYL)-6-BENZOXAZOLECARBOXYLATE | |
| BR112012019565A2 (pt) | formulações antimicrobianas com base em polissacarídeo | |
| EP4295903A3 (en) | Compositions and methods for treating farber disease | |
| EA201991023A1 (ru) | Фармацевтическая композиция для парентерального введения, содержащая карглумовую кислоту | |
| MX366894B (es) | Composiciones antimicrobianas y métodos para su producción. | |
| MX2020005573A (es) | Depsipeptidos endoparasitarios. | |
| MD20190080A2 (ru) | Кристаллические формы (s)-афоксоланера | |
| MX2009006656A (es) | Formulaciones homogeneas en pasta y gel. | |
| NZ769696A (en) | Endoparasitic depsipeptides | |
| CN109476711A (zh) | 防治猪鼻霉浆菌感染的组合物及生产该组合物的方法 | |
| BR112022009228A2 (pt) | Vacinas antimicrobianas de baixa contaminação | |
| WO2016072854A3 (en) | Pantothenamide analogues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20200317 |